On June 17, the U.S. Senate voted to pass the GENIUS Act (Act), which, if passed by the U.S. House of Representatives, would establish federal guardrails and a regulatory framework for stablecoins. Specifically, the Act...more
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. While the year saw an overall decline in M&A activity (down...more